These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17668337)

  • 61. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
    Wozniak L; Prakash M; Taylor M; Wild TC
    Int J Drug Policy; 2007 Oct; 18(5):388-96. PubMed ID: 17854727
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stimulant injectors in Ukraine: the next wave of the epidemic?
    Booth RE; Lehman WE; Kwiatkowski CF; Brewster JT; Sinitsyna L; Dvoryak S
    AIDS Behav; 2008 Jul; 12(4):652-61. PubMed ID: 18264752
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of hepatitis C infection in injection drug users in Hong Kong.
    Lee SS
    Hong Kong Med J; 2009 Dec; 15 Suppl 8():45-6. PubMed ID: 20393214
    [No Abstract]   [Full Text] [Related]  

  • 64. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack.
    Macías J; Palacios RB; Claro E; Vargas J; Vergara S; Mira JA; Merchante N; Corzo JE; Pineda JA
    Liver Int; 2008 Jul; 28(6):781-6. PubMed ID: 18312289
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
    J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Staying safe from hepatitis C: engaging with multiple priorities.
    Harris M; Treloar C; Maher L
    Qual Health Res; 2012 Jan; 22(1):31-42. PubMed ID: 21873284
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.
    Lelutiu-Weinberger C; Pouget ER; Des Jarlais DD; Cooper HL; Scheinmann R; Stern R; Strauss SM; Hagan H
    Soc Sci Med; 2009 Feb; 68(3):579-90. PubMed ID: 19062148
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use.
    O'Brien SF; Xi G; Yi QL; Goldman M
    Transfus Med; 2010 Feb; 20(1):15-21. PubMed ID: 19793079
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study.
    Islam M; Stern T; Conigrave KM; Wodak A
    Drug Alcohol Rev; 2008 Jan; 27(1):13-9. PubMed ID: 18034377
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.
    Hickman M; Hope V; Brady T; Madden P; Jones S; Honor S; Holloway G; Ncube F; Parry J
    J Viral Hepat; 2007 Sep; 14(9):645-52. PubMed ID: 17697017
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.
    Rhodes T; Treloar C
    Addiction; 2008 Oct; 103(10):1593-603. PubMed ID: 18821870
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ; Maida I; Soriano V; Núnez M
    J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.
    Cavlek TV; Margan IG; Lepej SZ; Kolaric B; Vince A
    J Med Virol; 2009 Aug; 81(8):1348-53. PubMed ID: 19551819
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users.
    Mathei C; Shkedy Z; Denis B; Kabali C; Aerts M; Molenberghs G; Van Damme P; Buntinx F
    J Viral Hepat; 2006 Aug; 13(8):560-70. PubMed ID: 16901287
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
    Idrees M; Lal A; Naseem M; Khalid M
    J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.
    Thorpe LE; Ouellet LJ; Hershow R; Bailey SL; Williams IT; Williamson J; Monterroso ER; Garfein RS
    Am J Epidemiol; 2002 Apr; 155(7):645-53. PubMed ID: 11914192
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.